Nanomedicine for The Management of Lung and Blood Diseases

• Tam JM , McConvilleJT, WilliamsRO 3rd, Johnston KP: Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J. Pharm. Sci.97, 4915–4933 (2008).
   PubMed Web of Science ®Google Scholar
• Rogueda PG , TrainiD: The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects.Expert Opin. Drug Deliv.4, 595–606 (2007).
   PubMed Web of Science ®Google Scholar
• Rogueda PG , TrainiD: The nanoscale in pulmonary delivery. Part 2: formulation platforms.Expert Opin. Drug Deliv.4, 607–620 (2007).
   PubMed Web of Science ®Google Scholar
• Sung JC , PulliamBL, EdwardsDA: Nanoparticles for drug delivery to the lungs.Trends Biotechnol.25, 563–570 (2007).
   PubMed Web of Science ®Google Scholar
• Yang W , PetersJI, WilliamsRO 3rd: Inhaled nanoparticles – a current review. Int. J. Pharm.356, 239–247 (2008).
   PubMed Web of Science ®Google Scholar
• Smola M , VandammeT, SokolowskiA: Nanocarriers as pulmonary drug delivery systems to treat and diagnose respiratory and non respiratory diseases.Int. J. Nanomed.3, 1–19 (2008).
   PubMed Web of Science ®Google Scholar
• Heyder J , GebhartJ, RudolfG, SchillerC, StahlhofenW: Deposition of particles in the human respiratory tract in the size range 0.005–015 pm.J. Aerosol Sci.17, 811–825 (1986).
   Web of Science ®Google Scholar
• Arnold MM , GormanEM, SchieberLJ, MunsonEJ, BerklandC: NanoCipro encapsulation in monodisperse large porous PLGA microparticles.J. Control. Release121, 100–109 (2007).
   PubMed Web of Science ®Google Scholar
• Alvarez CA , WiederholdNP, McConvilleJTet al.: Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.J. Infect.55, 68–74 (2007).
   PubMed Web of Science ®Google Scholar
• Tagalakis AD , McAnultyRJ, DevaneyJet al.: A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer.Mol. Ther.16, 907–915 (2008).
   PubMed Web of Science ®Google Scholar
• Meers P , NevilleM, MalininVet al.: Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.J. Antimicrob. Chemother.61, 859–868 (2008).
   PubMed Web of Science ®Google Scholar
• Tseng C-L , Wu SY-H, Wang W-H et al.: Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. Biomaterials29, 3014–3022 (2008).
   PubMed Web of Science ®Google Scholar
• Gradishar WJ : Albumin-bound paclitaxel: a next-generation taxane.Expert Opin. Pharmacother.7, 1041–1053 (2006).
   PubMed Web of Science ®Google Scholar
• Rizvi NA , RielyGJ, AzzoliCGet al.: Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.J. Clin. Oncol.26, 639–643 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson CM , PandeyR, SharmaSet al.: Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis.Antimicrob. Agents Chemother.49, 4335–4338 (2005).
   PubMed Web of Science ®Google Scholar
• Ahmad Z , PandeyR, SharmaS, KhullerGK: Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticles.Int. J. Antimicrob. Agents31, 142–146 (2008).
   PubMed Web of Science ®Google Scholar
• Nguyen J , SteeleTWJ, MerkelO, ReulR, KisselT: Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy.J. Control. Release132, 243–251 (2008).
   PubMed Web of Science ®Google Scholar
• Kong X , ZhangW, LockeyRFet al.: Respiratory syncytial virus infection in Fischer 344 rats is attenuated by short interfering RNA against the RSV-NS1 gene.Genet. Vaccines Ther.5, 4 (2007).
   PubMedGoogle Scholar
• Griesenbach U , FerrariS, GeddesDM, AltonEW: Gene therapy progress and prospects: cystic fibrosis.Gene Ther.9, 1344–1350 (2002).
   PubMed Web of Science ®Google Scholar
• Li S-D , Chono S, Huang L: Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles. J. Control. Release126, 77–84 (2008).
   PubMed Web of Science ®Google Scholar
• Li S-D , Chono S, Huang L: Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol. Ther.16, 942–946 (2008).
   PubMed Web of Science ®Google Scholar
• Heidel JD , YuZ, LiuJYet al.: Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.Proc. Natl Acad. Sci. USA104, 5715–5721 (2007).
   PubMed Web of Science ®Google Scholar
• Dames P , GleichB, FlemmerAet al.: Targeted delivery of magnetic aerosol droplets to the lung.Nat. Nanotechnol.2, 495–499 (2007).
   PubMed Web of Science ®Google Scholar
• Sharma AK , ZhangL, LiSet al.: Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.J. Control. Release131, 220–227 (2008).
   PubMed Web of Science ®Google Scholar
• Reddy LH , DubernetC, MouelhiSLet al.: A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.J. Control. Release124, 20–27 (2007).
   PubMed Web of Science ®Google Scholar
• Reddy LH , MarquePE, DubernetCet al.: Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.J. Pharmacol. Exp. Ther.325, 484–890 (2008).
   PubMed Web of Science ®Google Scholar
• Reddy LH , FerreiraH, DubernetCet al.: Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.Anticancer Drugs19, 999–1006 (2008).
   PubMed Web of Science ®Google Scholar
• Schwulst SJ , MuenzerJT, Peck-PalmerOMet al.: Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis.Shock30, 127–134 (2008).
   PubMed Web of Science ®Google Scholar
• Kidane AG , BurriesciG, CornejoPet al.: Current developments and future prospects for heart valve replacement therapy.J. Biomed. Mater. Res. B Appl. Biomater.88, 290–303 (2009).
   PubMed Web of Science ®Google Scholar
• Nielsen VG , KirklinJK, HolmanWLet al.: Mechanical circulatory device thrombosis: a new paradigm linking hypercoagulation and hypofibrinolysis.ASAIO J.54, 351–358 (2008).
   PubMed Web of Science ®Google Scholar
• Jackson MJ , RobinsonGM, AliNet al.: Surface engineering of artificial heart valve disks using nanostructured thin films deposited by chemical vapour deposition and sol-gel methods.J. Med. Eng. Technol.30, 323–329 (2006).
   PubMedGoogle Scholar
• Mirensky TL , BreuerCK: The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications.Pediatr. Res.63, 559–568 (2008).
   PubMed Web of Science ®Google Scholar
• Ferraz N , CarlssonJ, HongJ, OttMK: Influence of nanoporesize on platelet adhesion and activation.J. Mater. Sci. Mater. Med.19, 3115–3121 (2008).
   PubMed Web of Science ®Google Scholar
• Ferraz N , NilssonB, HongJ, Karlsson Ott M: Nanoporesize affects complement activation. J. Biomed. Mater. Res. A87, 925–931 (2008).
   Google Scholar
• Marsh JN , SenpanA, HuGet al.: Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.Nanomed.2, 533–543 (2007).
   PubMed Web of Science ®Google Scholar
• Chua KN , ChaiC, LeePCet al.: Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells.Biomaterials27, 6043–6051 (2006).
   PubMed Web of Science ®Google Scholar
• Chua KN , ChaiC, LeePCet al.: Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells.Exp. Hematol.35, 771–781 (2007).
   PubMed Web of Science ®Google Scholar
• Nichols JE , CortiellaJ: Engineering of a complex organ: progress toward development of a tissue-engineered lung.Proc. Am. Thorac. Soc.5, 723–730 (2008).
   PubMedGoogle Scholar
• Chtourou S , PorteP, NogreMet al.: A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.Vox Sang.92, 327–337 (2007).
   PubMed Web of Science ®Google Scholar
• Kim IS , ChoiYW, KangYet al.: Improvement of virus safety of an antihemophilc factor IX by virus filtration process.J. Microbiol. Biotechnol.18, 1317–1325 (2008).
   PubMed Web of Science ®Google Scholar
• Terpstra FG , ParkkinenJ, ToloHet al.: Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.Vox Sang.90, 21–32 (2006).
   PubMed Web of Science ®Google Scholar
• Nel A , XiaT, MadlerL, LiN: Toxic potential of materials at the nanolevel.Science311, 622–627 (2006).
   PubMed Web of Science ®Google Scholar
• Card JW , ZeldinDC, BonnerJC, NestmannER: Pulmonary applications and toxicity of engineered nanoparticles.Am. J. Physiol. Lung Cell. Mol. Physiol.295, L400–L411 (2008).
   PubMed Web of Science ®Google Scholar
• Poland CA , DuffinR, KinlochIet al.: Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study.Nat. Nanotechnol.3, 423–428 (2008).
   PubMed Web of Science ®Google Scholar
• Radomski A , JuraszP, Alonso-EscolanoDet al.: Nanoparticle-induced platelet aggregation and vascular thrombosis.Br. J. Pharmacol.146, 882–893 (2005).
   PubMed Web of Science ®Google Scholar
• Li N , XiaT, NelAE: The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles.Free Radic. Biol. Med.44, 1689–1699 (2008).
   PubMed Web of Science ®Google Scholar
• Shaw SY , WestlyEC, PittetMJet al.: Perturbational profiling of nanomaterial biologic activity.Proc. Natl Acad. Sci. USA105, 7387–7392 (2008).
   PubMed Web of Science ®Google Scholar
• Guo J , SuH, ZengYet al.: Reknitting the injured spinal cord by self-assembling peptide nanofiber scaffold.Nanomed.3, 311–321 (2007).
   PubMed Web of Science ®Google Scholar
• Segers VF , TokunouT, HigginsLJet al.: Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.Circulation116, 1683–1692 (2007).
   PubMed Web of Science ®Google Scholar

Websites

• North American Cystic Fibrosis Conference Arikace™ Poster #285. www.transaveinc.com/NewsEvents.aspx?category=Articles&archive=false
   Google Scholar
• Multidose safety and tolerability study of Arikace™ for inhalation in cystic fibrosis patients. www.clinicaltrials.qov/ct2/show/NCT00558844
   Google Scholar
• A study to determine the safety and tolerability of Arikace™ versus placebo in patients who have bronchiectasis. www.clinicaltrials.qov/ct2/show/NCT00775138
   Google Scholar
• Safety study of CALAA-01 to treat solid tumor cancers. www.clinicaltrials.qov/ct2/show/NCT00689065
   Google Scholar